Little Green Pharma has successfully completed its first shipment of cannabis flower medicines to Australia from its recently acquired Danish Facility.
Dried flower medicine sales in Australia have seen an increase in demand as doctors become more comfortable with this method of administration, with cannabis flower frequently prescribed due to its rapid onset of therapeutic benefit.
“The import of this first shipment so quickly following the acquisition is a milestone achievement by our new Denmark team. To be able to meet all the regulatory requirements to supply and import product within this timeframe is a significant achievement and consistent with our reputation as a leading global medicinal cannabis business. Flower medicines are becoming increasingly popular with Australian doctors in prescribing to patients for quick onset of effects, mainly for breakthrough pain or to assist with sleep, and with access to this Denmark-grown product we are able to provide a new supply chain of high-quality, medicinal cannabis flower in an under-supplied market," says Fleta Solomon, managing director of Little Green Pharma.